Articles

Topical nepafenac as a treatment for CME

The Pascal dynamic contour tonometer (DCT) and Reichert ocular response analyser (ORA) are the best tools for measuring corneal-compensated intraocular pressure (IOPcc) in patients with keratoconus (KC), according to study results published in the British Journal of Ophthalmology, December.

When using bevacizumab to treat choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), a loading dose (LD) of bevacizumab is more effective than an as-needed (PRN) dosing schedule, according to study results published in the December issue of the British Journal of Ophthalmology.

Biaxial microincision cataract surgery (B-MICS) is more successful than traditional cataract surgery in improving optical performance and reducing higher order aberrations, according to study results published in the December issue of the British Journal of Ophthalmology.

PDT and ranibizumab combination therapy results

Bevacizumab and glaucoma changes

Pegaptanib sodium therapy is safe in patients with neovascular age-related macular degeneration (NV-AMD) up to three years, according to study results published in the December issue of the British Journal of Ophthalmology.

Endophthalmitis incidence after intravitreal injections

Trabeculectomy with or without MMC: 9-year data

Views of glaucoma patients on provision of follow-up care

Paediatric strabismus, particularly exotropia, increases the likelihood of psychiatric disease in later life, according to study results published in the November issue of Pediatrics.

Keratoconus diagnosis with OCT

A multimedia campaign may be the best way to raise glaucoma awareness in the UK, according to study results published in the December issue of the British Journal of Ophthalmology.

Dynamic stimulation of accommodation

It is possible to administer verteporfin and ranibizumab on the same day without adverse events, according to study results published in the December issue of the British Journal of Ophthalmology.

Changes in wavefront aberrations in MICS

Highlights from the 2008 meeting of the American Academy of Ophthalmology (AAO)

I do not believe that safe and effective SBK can be performed with a microkeratome.

STAAR Surgical has created the Collamer Accommodating Study Team (CAST), a group of seven ophthalmologists who will investigate the accommodative properties of STAAR's Collamer intraocular lens (IOL).

It is up to our refractive surgery colleagues to publish their results on such patients to allow us to put some, or all, of our questions to rest.

All the latest product news and developments, December 2008

Although 25 G sutureless vitrectomy has increased in popularity, it is associated with postoperative complications including hypotony, choroidal detachment, and endophthalmitis. Richard Kaiser, MD, from the Retina Service of Wills Eye Institute, Philadelphia, noted that the 25 G procedure has a 12.4 times greater risk of endophthalmitis when compared with the 20 G procedure.

Three-year results from the Tube versus Trabeculectomy Study showed that tube-shunt surgery was more likely than trabeculectomy with mitomycin C to maintain IOP control and avoid persistent hypotony, loss of light perception vision, or re-operation for glaucoma.

Until I see research to convince me otherwise, steroid therapy will continue to be my drug of choice.

We should not be adding another drug to the therapeutic mix without having established the efficacy and side effect profile of a single therapy.

Despite the higher rate of prevalence in women, it is men who are more likely to suffer severe vision loss as a result of idiopathic intracranial hypertension (IIH), according to study results published online ahead of print by Neurology.

25 G surgery offers enhanced patient comfort as well as faster postoperative recovery.

There are those who say that blue or violet light actually benefits the eye. If this is true, we must have evolved really badly.

Administering fixed combinations as first-line treatment allows us to understand quickly whether our patients are non-responders or insufficient responders.

All the latest news and industry developments in focus, December 2008